Table 3.
Summary of overall survival analyses by univariate and multivariate COX regression analyses in non-metastatic patients
| Risk factors | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| HR (95 % CI) | P | HR (95 % CI) | P | |
| Sex | 1.52 (0.56–4.09) | 0.409 | ||
| Age (years) | 0.34 (0.13–0.86) | 0.023 | 0.42 (0.15–1.23) | 0.113 |
| Tumor location | 1.50 (0.66–3.41) | 0.330 | ||
| T | 5.54 (1.05–41.11) | 0.034 | 5.45 (0.68–43.51) | 0.109 |
| N | 1.79 (0.79–4.08) | 0.162 | ||
| Grade | 1.44 (0.34–6.16) | 0.623 | ||
| CEA | 1.08 (0.45–2.64) | 0.861 | ||
| SNHG20 (high/low) | 2.32 (1.11–5.36) | 0.019 | 1.63 (1.22–3.98) | 0.011 |
Statistical significance is highlighted by bold font
T depth of tumor, N lymph node, CEA carcino-embryonic antigen, HR hazard ratio, CI confidence, interval